Research ArticleTheranostics
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M. Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Zachary Ells, Sophie C. Kunte, Josef Zahner, Adrien Holzgreve, Mathias J. Zacherl, Gabriel T. Sheikh, Jozefina Casuscelli, Julien Leenhardt, Kenneth J. Pienta, Emmanuelle Jacquet, Mathieu Laramas, Jerome Long, Marine Faure, Ghislaine Reboulet, Channing J. Paller, Alexis Mercier, Lilja B. Solnes, Kevin Kiraz, Harun Ilhan, Andrei Gafita and Loïc Djaileb
Journal of Nuclear Medicine April 2025, jnumed.124.269431; DOI: https://doi.org/10.2967/jnumed.124.269431
Lena M. Unterrainer
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
2Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany;
3Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
Nicolas De Leiris
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Marcus Unterrainer
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
5Department of Radiology, University Hospital LMU Munich, Munich, Germany;
Astrid Delker
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
Linus Hempel
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
Zachary Ells
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
3Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
Sophie C. Kunte
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
2Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany;
Josef Zahner
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
Adrien Holzgreve
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
3Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
Mathias J. Zacherl
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
Gabriel T. Sheikh
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
Jozefina Casuscelli
6Department of Urology, University Hospital LMU Munich, Munich, Germany;
Julien Leenhardt
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Kenneth J. Pienta
7Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland;
Emmanuelle Jacquet
8Medical Oncology Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Mathieu Laramas
8Medical Oncology Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Jerome Long
9Institut Daniel Hollard, Mutualist Hospital Group, Grenoble, France;
Marine Faure
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Ghislaine Reboulet
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Channing J. Paller
10Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland;
Alexis Mercier
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Lilja B. Solnes
11Division of Nuclear Medicine and Molecular Imaging; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland; and
12Johns Hopkins Theranostics Center, Baltimore, Maryland
Kevin Kiraz
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;
Harun Ilhan
1Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany;
5Department of Radiology, University Hospital LMU Munich, Munich, Germany;
Andrei Gafita
11Division of Nuclear Medicine and Molecular Imaging; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland; and
12Johns Hopkins Theranostics Center, Baltimore, Maryland
Loïc Djaileb
4Nuclear Medicine Department, University Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M. Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Zachary Ells, Sophie C. Kunte, Josef Zahner, Adrien Holzgreve, Mathias J. Zacherl, Gabriel T. Sheikh, Jozefina Casuscelli, Julien Leenhardt, Kenneth J. Pienta, Emmanuelle Jacquet, Mathieu Laramas, Jerome Long, Marine Faure, Ghislaine Reboulet, Channing J. Paller, Alexis Mercier, Lilja B. Solnes, Kevin Kiraz, Harun Ilhan, Andrei Gafita, Loïc Djaileb
Journal of Nuclear Medicine Apr 2025, jnumed.124.269431; DOI: 10.2967/jnumed.124.269431
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M. Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Zachary Ells, Sophie C. Kunte, Josef Zahner, Adrien Holzgreve, Mathias J. Zacherl, Gabriel T. Sheikh, Jozefina Casuscelli, Julien Leenhardt, Kenneth J. Pienta, Emmanuelle Jacquet, Mathieu Laramas, Jerome Long, Marine Faure, Ghislaine Reboulet, Channing J. Paller, Alexis Mercier, Lilja B. Solnes, Kevin Kiraz, Harun Ilhan, Andrei Gafita, Loïc Djaileb
Journal of Nuclear Medicine Apr 2025, jnumed.124.269431; DOI: 10.2967/jnumed.124.269431
Jump to section
Related Articles
Cited By...
- No citing articles found.